The PG Dip in Pharmaceutical and Biopharmaceutical Engineering is a part-time modular degree which can be taken over 24 months to 60 months. You will have the opportunity to gain a formal qualification in areas of particular concern to the bio/pharmaceutical industry that you may not have benefited from before, including issues such as product containment, powder/particle technology, design of API and secondary production facilities, current Good Manufacturing Practice (cGMP), design of classified facilities, aseptic processing facility design and validation.
Many graduates working in the pharmaceutical industries with a scientific background find themselves working in areas which increasingly overlap with engineers and engineering. Many would like to develop an engineering-based understanding of processes and production in a formal manner. This course offers you the opportunity to do this, developing your skills set and employability across a wider range of roles.
The course also presents the pharmaceutical and biopharmaceutical industry with an opportunity to enable greater cohesion and understanding among inter- and multi-disciplinary teams as graduates with science backgrounds receive a formal qualification in engineering.
The PGDip involves taking 12 modules to the value of ECTS 60 credits. Taught modules are offered on a cyclical basis. Six modules are taken per annum over a two year period if you opt for full registration, although the course can be taken over a maximum of five years. The choice of modules is subject to the approval of the course coordinator. Candidates who achieve an average of 50% in all taught modules may apply for entry to the MEngSc to complete a thesis.
Students take 60 credits from the following:
Offered in 2015/16
PE6010 Pharmaceutical Engineering (5 credits) PE6011 Biopharmaceutical Engineering (5 credits) PE6012 Pharmaceutical Process Equipment, Materials and Mechanical Design (5 credits) PE6013 Powder & Particle Technology and Unit Operations (5 credits) PE6014 Chemical Kinetics, Reactor Design and Bioreactor Engineering (5 credits) PE6015 Environmental Engineering in the Pharmaceutical Sector (5 credits) PE6023 Pharmaceutical and Biopharmaceutical Utilities (5 credits) PE6025 Advanced Health & Safety Management (5 credits)
Offered in 2016/17
PE6016 Pharmaceutical Industry, Manufacturing and Optimisation (5 credits) PE6017 Pharmaceutical Plant Design and Project Management (5 credits) PE6018 Pharmaceutical Process Validation and Quality (5 credits) PE6019 Process Analytical Technology (5 credits) PE6022 Aseptic Manufacturing Design (5 credits) PF6302 Introduction to Pharmaceutics: Formulation Science (5 credits) PE6024 Advanced Process Design & Safety Engineering (5 credits) PE6025 Advanced Health & Safety Management (5 credits)
Part II (MEngSc only)
PE6021 Dissertation in Pharmaceutical and Biopharmaceutical Engineering (30 credits)
Students will study at a UCC partner university in China and take the equivalent of 60 credits there in the Third Year.
Assessment is by continuous assessment and end of period exams.
The course offers graduates working in the pharmaceutical industry the opportunity to further develop your skills set and employability across a wider range of roles in the industry through enhanced continuing professional development.
Through the opportunities provided by participation on the programme, you are provided with opportunities to enable greater cohesion and understanding among inter-and multi-disciplinary teams while earning a formal qualification in engineering.